What one share of Medpace Holdings holds
We are one of the world’s leading clinical contract research organizations, or CROs, by revenue, solely focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries.
Medpace Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-09-30; the balance sheet is as of 2026-09-30.
| Sales | $98.83 |
|---|---|
| Profit | $18.03 |
| Capex (buildings and equipment) | $1.93 |
| Free cash flow | $23.25 |
| Cash and investments | $25.22 |
| Book value | $20.92 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | $11.45 | −$0.28 | $0.21 | $2.53 | — | $12.67 |
| 2016 | $11.60 | $0.37 | $0.37 | $2.15 | — | $15.02 |
| 2017 | $10.95 | $0.98 | $0.29 | $2.15 | — | $14.36 |
| 2018 | $19.09 | $1.97 | $0.43 | $3.81 | — | $16.79 |
| 2019 | $22.91 | $2.67 | $0.48 | $4.90 | — | $20.14 |
| 2020 | $24.56 | $3.84 | $0.83 | $6.03 | — | $22.69 |
| 2021 | $30.30 | $4.81 | $0.75 | $6.24 | — | $26.47 |
| 2022 | $43.36 | $7.28 | $1.10 | $10.43 | — | $12.43 |
| 2023 | $59.23 | $8.88 | $1.15 | $12.46 | — | $18.18 |
| 2024 | $65.88 | $12.63 | $1.14 | $17.88 | — | $26.95 |
| 2025 | $85.69 | $15.28 | $1.06 | $23.09 | — | $16.18 |
Common questions about Medpace Holdings
How much does one share of Medpace Holdings earn?
Over the last 12 months, each share of Medpace Holdings earned $18.03 of profit on $98.83 of sales, keeping about 18¢ of every $1 (profit margin).
Does Medpace Holdings pay a dividend?
Medpace Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Medpace Holdings’s book value per share?
Medpace Holdings’s book value is $20.92 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of September 30, 2026.
How much cash and debt does each share of Medpace Holdings have?
Each share of Medpace Holdings has $25.22 of cash and investments, as of September 30, 2026.
What is Medpace Holdings’s free cash flow per share?
$23.25 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Medpace Holdings bought back shares?
Medpace Holdings’s share count fell about 6% from 2015 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.